Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines UMC Q1 2026 Earnings Massive EPS Beat Signals Strong Operational Leverage COSO Q1 2026 Earnings EPS Misses Estimates amid Tightening Margins ArtsWay Manufacturing Q4 2024 Earnings Modest Profitability Sustained Amid Quiet Quarter QURE Q1 2026 Earnings NarrowerthanExpected Loss Amid Gene Therapy Pipeline Progress KB Financial Group Q4 2025 Earnings Strong EPS Beat Offsets Modest Stock Decline